141 related articles for article (PubMed ID: 37104086)
1. ADAR1 affects gastric cancer cell metastasis and reverses cisplatin resistance through AZIN1.
Wang H; Yang L; Liu R; He H; Zhang M; Xu Y
Anticancer Drugs; 2023 Nov; 34(10):1132-1145. PubMed ID: 37104086
[TBL] [Abstract][Full Text] [Related]
2. Enhanced AZIN1 RNA editing and overexpression of its regulatory enzyme ADAR1 are important prognostic biomarkers in gastric cancer.
Okugawa Y; Toiyama Y; Shigeyasu K; Yamamoto A; Shigemori T; Yin C; Ichikawa T; Yasuda H; Fujikawa H; Yoshiyama S; Hiro J; Ohi M; Araki T; Kusunoki M; Goel A
J Transl Med; 2018 Dec; 16(1):366. PubMed ID: 30563560
[TBL] [Abstract][Full Text] [Related]
3. Targeting ADAR1 suppresses progression and peritoneal metastasis of gastric cancer through Wnt / β-catenin pathway.
Li Z; Huang Y; Xu Y; Wang X; Wang H; Zhao S; Liu H; Yu G; Che X
J Cancer; 2021; 12(24):7334-7348. PubMed ID: 35003354
[No Abstract] [Full Text] [Related]
4. Adenosine Receptor A2B Antagonist Inhibits the Metastasis of Gastric Cancer Cells and Enhances the Efficacy of Cisplatin.
Wang H; Tan F; Xu Y; Ma Y; Li Y; Xiao H
Technol Cancer Res Treat; 2023; 22():15330338221150318. PubMed ID: 36786018
[TBL] [Abstract][Full Text] [Related]
5. ADAR1 and AZIN1 RNA editing function as an oncogene and contributes to immortalization in endometrial cancer.
Nakamura K; Shigeyasu K; Okamoto K; Matsuoka H; Masuyama H
Gynecol Oncol; 2022 Aug; 166(2):326-333. PubMed ID: 35697535
[TBL] [Abstract][Full Text] [Related]
6. RNA editing of AZIN1 coding sites is catalyzed by ADAR1 p150 after splicing.
Xing Y; Nakahama T; Wu Y; Inoue M; Kim JI; Todo H; Shibuya T; Kato Y; Kawahara Y
J Biol Chem; 2023 Jul; 299(7):104840. PubMed ID: 37209819
[TBL] [Abstract][Full Text] [Related]
7. Activation of AZIN1 RNA editing is a novel mechanism that promotes invasive potential of cancer-associated fibroblasts in colorectal cancer.
Takeda S; Shigeyasu K; Okugawa Y; Yoshida K; Mori Y; Yano S; Noma K; Umeda Y; Kondo Y; Kishimoto H; Teraishi F; Nagasaka T; Tazawa H; Kagawa S; Fujiwara T; Goel A
Cancer Lett; 2019 Mar; 444():127-135. PubMed ID: 30583079
[TBL] [Abstract][Full Text] [Related]
8. Adenovirus-mediated TIPE2 overexpression inhibits gastric cancer metastasis via reversal of epithelial-mesenchymal transition.
Yin H; Huang X; Tao M; Hu Q; Qiu J; Chen W; Wu J; Xie Y
Cancer Gene Ther; 2017 Apr; 24(4):180-188. PubMed ID: 28186089
[TBL] [Abstract][Full Text] [Related]
9. Circular RNA hsa_circ_0004872 inhibits gastric cancer progression via the miR-224/Smad4/ADAR1 successive regulatory circuit.
Ma C; Wang X; Yang F; Zang Y; Liu J; Wang X; Xu X; Li W; Jia J; Liu Z
Mol Cancer; 2020 Nov; 19(1):157. PubMed ID: 33172486
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of ATM reverses EMT and decreases metastatic potential of cisplatin-resistant lung cancer cells through JAK/STAT3/PD-L1 pathway.
Shen M; Xu Z; Xu W; Jiang K; Zhang F; Ding Q; Xu Z; Chen Y
J Exp Clin Cancer Res; 2019 Apr; 38(1):149. PubMed ID: 30961670
[TBL] [Abstract][Full Text] [Related]
11. [miR-497 inhibits the growth and metastasis of SGC-7901 human gastric cancer anoikis resistant cells via blocking Wnt/β-catenin signaling pathway].
Yu L; Xu Y; Yang J; Gao L; Li H; Wang Z; Zhang Z; Ling Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Jul; 39(7):617-625. PubMed ID: 37403721
[TBL] [Abstract][Full Text] [Related]
12. Circular RNA circ_0001017 Sensitizes Cisplatin-Resistant Gastric Cancer Cells to Chemotherapy by the miR-543/PHLPP2 Axis.
Zhang J; Zha W; Qian C; Ding A; Mao Z
Biochem Genet; 2022 Apr; 60(2):558-575. PubMed ID: 34313883
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of FAM3B Promotes Cisplatin Resistance in Gastric Cancer by Inducing Epithelial-Mesenchymal Transition.
Song C; Duan C
Med Sci Monit; 2020 May; 26():e921002. PubMed ID: 32442162
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-34 promotes the proliferation and epithelial-mesenchymal transition of gastric cancer cells.
Li CH; Chen ZM; Chen PF; Meng L; Sui WN; Ying SC; Xu AM; Han WX
World J Gastrointest Oncol; 2022 Oct; 14(10):1968-1980. PubMed ID: 36310707
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of
Tian J; Li Z; Jiang Y; Gu W; Kong E; Hao Q; Kong B; Sun L
Rejuvenation Res; 2022 Oct; 25(5):243-252. PubMed ID: 36039935
[TBL] [Abstract][Full Text] [Related]
16. AZIN1 RNA editing confers cancer stemness and enhances oncogenic potential in colorectal cancer.
Shigeyasu K; Okugawa Y; Toden S; Miyoshi J; Toiyama Y; Nagasaka T; Takahashi N; Kusunoki M; Takayama T; Yamada Y; Fujiwara T; Chen L; Goel A
JCI Insight; 2018 Jun; 3(12):. PubMed ID: 29925690
[TBL] [Abstract][Full Text] [Related]
17. KLF5-mediated aquaporin 3 activated autophagy to facilitate cisplatin resistance of gastric cancer.
Dai X; Chen Y; Chen N; Dou J; Zhuang H; Wang J; Zhao X; Zhang X; Zhao H
Immunopharmacol Immunotoxicol; 2023 Apr; 45(2):140-152. PubMed ID: 36083020
[TBL] [Abstract][Full Text] [Related]
18. Dihydroartemisinin suppresses proliferation, migration, the Wnt/β-catenin pathway and EMT via TNKS in gastric cancer.
Ma Y; Zhang P; Zhang Q; Wang X; Miao Q; Lyu X; Cui B; Ma H
Oncol Lett; 2021 Oct; 22(4):688. PubMed ID: 34457043
[TBL] [Abstract][Full Text] [Related]
19. Forkhead Box Protein C2 Promotes Epithelial-Mesenchymal Transition, Migration and Invasion in Cisplatin-Resistant Human Ovarian Cancer Cell Line (SKOV3/CDDP).
Li C; Ding H; Tian J; Wu L; Wang Y; Xing Y; Chen M
Cell Physiol Biochem; 2016; 39(3):1098-110. PubMed ID: 27562816
[TBL] [Abstract][Full Text] [Related]
20. CDK-associated Cullin 1 can promote cell proliferation and inhibit cisplatin-induced apoptosis in the AGS gastric cancer cell line.
Zheng Q; Zhao LY; Kong Y; Nan KJ; Yao Y; Liao ZJ
World J Surg Oncol; 2013 Jan; 11():5. PubMed ID: 23311997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
